1. WHO. Classification of Diabetes Mellitus 2019. World Health Organization. 2019. p. 6–7.
2. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et
al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.
Diabetes Res Clin Pract. 2017;128:40–50.
3. Zelnick LR, Weiss NS, Kestenbaum BR, Robinson-Cohen C, Heagerty PJ, Tuttle K, et al.
Diabetes and CKD in the United States population, 2009–2014. Clin J Am Soc Nephrol.
2017;12(12):1984–90.
4. Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and
associated chronic kidney disease. Vol. 12, Nature Reviews Nephrology. 2016. p. 73–81.
5. Vallon V. The proximal tubule in the pathophysiology of the diabetic kidney. Am J Physiol -
Regul Integr Comp Physiol. 2011;300(5).
6. Anders HJ, Huber TB, Isermann B, Schiffer M. CKD in diabetes: Diabetic kidney disease
versus nondiabetic kidney disease. Nat Rev Nephrol.2018;14(6):361–77.
7. Lim AKH. Diabetic nephropathy--complications and treatment. Int J Nephrol Renovasc Dis.
2014;7(1):361–81.
8. Luiza M, Caramori A, Rossing P. Chapter 54 – Diabetic Nephropathy. Seventh Ed. Vol. 5,
Endocrinology: Adult & Pediatric. Elsevier; 2018. 934–57.
9. Rossing P, Fioretto P, Parving BFH. 39 - Diabetic Nephropathy. Tenth Edit. Vol. 5, Brenner
and Rector’s The Kidney, 2-Volume Set. Elsevier Inc.; 2018. 1283-321.
10. Gluhovschi C, Gluhovschi G, Petrica L, Timar R, Velciov S, Ionita I, et al. Urinary
Biomarkers in the Assessment of Early Diabetic Nephropathy. J Diabetes Res. 2016;1–13.
11. Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: Challenges, progress, and
possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032–45.
12. Kramer HJ, Nguyen QD, Curhan G, Hsu CY. Renal Insufficiency in the Absence of
Albuminuria and Retinopathy among Adults with Type 2 Diabetes Mellitus. J Am Med
Assoc. 2003;289(24):3273–7.
13. Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR. Risk factors for renal dysfunction
in type 2 diabetes: U.K. Prospective Diabetes Study. Diabetes. 2006;55(6):1832–9.
14. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012
Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
Kidney Int Suppl. 2013;3(1):1–163.
15. Chevalier RL. The proximal tubule is the primary target of injury and progression of kidney
disease: Role of the glomerulotubular junction. Am J Physiol - Ren Physiol.
2016;311(1):145–61.
16. Tramonti G, Kanwar YS. Review and discussion of tubular biomarkers in the diagnosis and
management of diabetic nephropathy. Endocrine. 2013;43(3):494–503.
17. Papadopoulou-Marketou N, Kanaka-Gantenbein C, Marketos N, Chrousos GP, Papassotiriou
I. Biomarkers of diabetic nephropathy: A 2017 update. Crit Rev Clin Lab Sci.
2017;54(5):326–42.
18. American Diabetes Associaton. Standards of Medical Care in Diabetes: Microvascular
Complications and Foot Care. Diabetes Care. 2018;41:S105–18.
19. PERKENI. Konsensus Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Di Indonesia.
PB. Perkeni; 2015. p. 1–79.
20. Campion CG, Sanchez-ferras O, Batchu SN. Potential Role of Serum and Urinary
Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy. Can J Kidney Heal Dis.
2017;4:1–18.
21. Devuyst O, Olinger E, Rampoldi L. Uromodulin: From physiology to rare and complex
kidney disorders. Nat Rev Nephrol. 2017;13(9):525–44.
22. Fedak D, Kuzniewski M, Fugiel A, Wieczorek-Surdacka E, Przepiorkowska-Hoyer B, Jasik
P, et al. Serum uromodulin concentrations correlate with glomerular filtration rate in patients
with chronic kidney disease. Pol Arch Med Wewn. 2016;126(12):995–1004.
23. Micanovic R, LaFavers K, Garimella PS, Wu XR, El-Achkar TM. Uromodulin (Tamm-
Horsfall protein): guardian of urinary and systemic homeostasis. Nephrol Dial Transplant.
2020;35(1):33–43.
24. Lhotta K. Uromodulin and Chronic Kidney Disease. Kidney Blood Press Res. 2010;33:393–8
25. Rampoldi L, Scolari F, Amoroso A, Ghiggeri G, Devuyst O. The rediscovery of uromodulin
(Tamm-Horsfall protein): From tubulointerstitial nephropathy to chronic kidney disease.
Kidney Int. 2011;80(4):338–47.
26. Halankar A, Shalia K. Uromodulin Levels in Chronic Kidney Disease. Int J Biomed Adv Res
IJBAR Int J Biomed Adv Res J. 2016;8:383–7.
27. Dawson B, Trapp RG. Basic & Clinical Biostatistics, 4th Edition. 4th ed. Foltin J, Lebowitz
H, Fernando N, editors. Physics. Illinois: McGraw-Hill Education; 2004.
28. Vaidya SR. Chronic renal failure. Sci Basis Urol Second Ed. 2019;2:1–14.
29. AlFehaid A. Prevalence of microalbuminuria and its correlates among diabetic patients
attending diabetic clinic at National Guard Hospital in Alhasa. J Fam Community Med.
2017;24(1):1.
30. Inassi J, Vijayalakshmy R. Role of Duration of Diabetes In The Development of
Nephropathy In Type 2 Diabetic Patients. Natl J Med Res. 2013;3(1):8–11.
31. Stephen R, Jolly SE, Nally J V., Navaneethan SD. Albuminuria: When urin predicts kidney
and cardiovascular disease. Cleve Clin J Med.2014;81(1):41–50.
32. Pyram R, Kansara A, Ann M, Loney-hutchinson L. Chronic kidney disease and diabetes.
Maturitas. 2012;71(2):94–103.
33. George JA, Gounden V. Novel glomerular filtration markers. Adv Clin Chem. 2019;88:91–
119.
34. Lin Y-C, Chang Y-H, Yang S-Y, Wu K-D, Chu T-S. Update of pathophysiology and
management of diabetic kidney diseases. J Intern Med Taiwan. 2018;29(4):240–9.
35. El-Achkar TM, Wu XR. Uromodulin in kidney injury: An instigator, bystander, or protector?
Am J Kidney Dis. 2012;59(3):452–61.
36. Steubl D, Block M, Herbst V, Nockher WA, Schlumberger W, Satanovskij R, et al. Plasma
Uromodulin Correlates With Kidney Function and Identifies Early Stages in Chronic Kidney
Disease Patients. Med J. 2016;95(10):1–9.
37. Garimella PS, Biggs ML, Katz R, Bennett MR, Devarajan P, Kestenbaum BR, et al. Urinary
uromodulin, kidney function and cardiovascular disease in elderly adults. Kidney Int.
2015;88(5):1126–34.
38. cherberich E, Gruber R, Nockher WA, Christensen EI, Schmitt H, Schlumberger W, et al.
Serum uromodulin — a marker of kidney function and renal parenchymal integrity. Nephrol
Dial Transplant. 2017;33:284–95.
39. Steubl D, Buzkova P, Garimella PS, Ix JH, Devarajan P, Bennett MR, et al. Association of
Serum Uromodulin With ESKD and Kidney Function Decline in the Elderly: The
Cardiovascular Health Study. Am J Kidney Dis.2019;74(4):501–9.
40. Leiherer A, Muendlein A, Saely CH, Brandtner EM, Geiger K, Fraunberger P, et al. The
value of uromodulin as a new serum marker to predict decline in renal function. J Hypertens.
2018;36(1):110–8.
41. Lou NJ, Ni YH, Jia HY, Deng JT, Jiang L, Zheng FJ, et al. Urinary Microvesicle-Bound
Uromodulin: A Potential Molecular Biomarker in Diabetic Kidney Disease. J Diabetes Res.
2017;1–6.
42. Wiromrat P, Bjornstad P, Roncal C, Pyle L, Johnson RJ, Cherney DZ, et al. Serum
uromodulin is associated with urinary albumin excretion in adolescents with type 1 diabetes.
J Diabetes Complications. 2019;33(9):648–50.
43. Ibrahim AA, Baban RS, Khudair MS. Clinical and biochemical association between serum
and urin level of the uromodulin protein with albuminuria in patients with type-2 diabetes
mellitus. Biochem Cell Arch. 2019;19:2367–70.
44. Kottgen A, Shih-jen H, GM L, Qin F, EJ B, Dehghan A. Uromodulin Levels Associate with a
Common UMOD Variant and Risk for Incident CKD. J Am Soc Nephrol. 2010;337–44.
45. Prajczer S, Heidenreich U, Pfaller W, Kotanko P, Lhotta K, Jennings P. Evidence for a role
of uromodulin in chronic kidney disease progression. Nephrol Dial Transplant.
2010;25(January):1896–903.